NCT01760148 - Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2) | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2014

Conditions

Hepatitis C, ChronicLiver DiseasesInterferon Deficiency

Interventions

DRUG

interferon alpha 2b

"Interferon:dosage,5 million units/person;frequency,every other day (qod);duration,48 weeks;Subcutaneous injection.~Ribavirin: dosage,15mg/kg/day;frequency,three times a day (t.i.d);duration,48 weeks;take orally."

Trial Locations (1)

130061

RECRUITING

First Hospital Jilin University, Changchun